Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that lncRNA
PLAC2
can inhibit glioma. This study explored the function of
PLAC2
in
hepatocellular carcinoma
(
HCC
). Our data showed that
PLAC2
expression in
HCC
was not affect by HCV and HBV infection, while
PLAC2
levels were significantly lower in
HCC
tissues comparing to non-cancer tissues. Low
PLAC2
levels in
HCC
tissues were associated with low overall 5-year survival rate. P53 mRNA was also downregulated in
HCC
and positively correlated with
PLAC2
.
PLAC2
overexpression caused upregulated p53 and increase cancer cell apoptosis. P53 overexpression failed to affect
PLAC2
. In addition, p53 silencing reduced the effects of
PLAC2
overexpression. Therefore,
PLAC2
upregulated p53 to mediate cancer cell apoptosis.
...
PMID:LncRNA PLAC2 upregulates p53 to induce hepatocellular carcinoma cell apoptosis. 3123 63